Children Tumor Foundation Expands into a New Strategic Chapter as Impact Investor in NF Research
Scientists have successfully developed a drug that could help treat rare brain damage (NF1) patients in the UK. The BBC’s weekly The Lancet series profiles different experts from around the world, from across the continent and the US. They explain why.
Source: prweb.comPublished on 2023-01-10
Related news
- Scientists make progress in using DNA to store data
- UBIX and ORS GROUP announce partnership to democratize advanced analytics and AI for small and midmarket organizations
- Research Grant Supports Sterile Medical Packaging Innovation
- Scientists use machine learning to fast - track drug formulation development
- The technology pilot projects helping farmers adapt to climate change and gain economic benefits
- Kasi Cloud breaks ground on first Nigeria campus
- Using machine learning models to guide the design of long - acting injectable drug formulations